Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
BIOL Biolase
0.581
-0.001-0.17%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Total revenue
26.01% 12.01M 33.95% 12.24M 25.26% 10.17M 72.03% 39.19M
Operating revenue
26.01% 12.01M 33.95% 12.24M 25.26% 10.17M 72.03% 39.19M
Cost of revenue
103.99% 9.57M 39.29% 7.09M 1.15% 5.44M 36.44% 22.66M
Gross profit
-49.50% 2.45M 27.22% 5.14M 72.53% 4.73M 167.76% 16.53M
Operating expense
35.15% 10.1M 40.60% 10.2M 1.50% 8.94M 32.12% 32.65M
Selling and administrative expenses
36.88% 8.12M 40.28% 8.54M 5.59% 7.39M 26.57% 26.6M
-Selling and marketing expense
45.12% 5.01M 63.15% 5.4M 35.49% 4.81M 36.44% 15.34M
-General and administrative expense
25.41% 3.11M 13.03% 3.14M -25.24% 2.58M 15.21% 11.26M
Research and development costs
28.51% 1.98M 42.25% 1.65M -14.36% 1.54M 63.68% 6.05M
Operating profit
-191.13% -7.65M -57.43% -5.06M 30.62% -4.21M 13.06% -16.12M
Net non-operating interest income expense
25.48% -424K 26.12% -430K 24.70% -433K 5.72% -2.22M
Non-operating interest expense
-25.48% 424K -26.12% 430K -24.70% 433K -5.72% 2.22M
Other net income (expense)
-406.15% -329K -103.42% -103K 41.18% -120K -46.42% 2.25M
Gain on sale of security
-813.89% -329K -249.28% -103K 41.18% -120K -2,052.38% -452K
Special income (charges)
-- 0 -- 0 -- 0 -- 2.7M
-Less:Other special charges
-- -- -- -- -- -- -- -2.7M
Income before tax
-157.63% -8.4M -614.58% -5.59M 30.43% -4.76M 3.64% -16.09M
Income tax
-221.43% -17K 128.75% 23K -71.67% 17K -49.22% 65K
Net income
-156.01% -8.39M -699.29% -5.61M 30.79% -4.78M 3.99% -16.16M
Net income continuous Operations
-156.01% -8.39M -699.29% -5.61M 30.79% -4.78M 3.99% -16.16M
Minority interest income
Net income attributable to the parent company
-156.01% -8.39M -699.29% -5.61M 30.79% -4.78M 3.99% -16.16M
Preferred stock dividends
-59.21% 217K -96.86% 546K
Other preferred stock dividends
Net income attributable to common stockholders
-155.31% -8.39M -692.51% -5.61M 32.83% -4.99M 51.17% -16.7M
Basic earnings per share
-120.00% -1.1 -674.61% -0.91 46.00% -0.81 80.36% -2.75
Diluted earnings per share
-120.00% -1.1 -674.61% -0.91 46.00% -0.81 80.36% -2.75
Dividend per share
0 0 0 0
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.
CEO: Mr. John R. Beaver
Market: NASDAQ
Listing Date: 11/12/1992
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist